4//SEC Filing
Eckelman Brendan P. 4
Accession 0001739614-24-000033
CIK 0001739614other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:15 PM ET
Size
7.8 KB
Accession
0001739614-24-000033
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Eckelman Brendan P.
DirectorChief Scientific Officer10% Owner
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-05-22$34.12/sh−2,510$85,641→ 6,667 totalExercise: $33.63Exp: 2031-01-15→ Common Stock (2,510 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-05-22$34.12/sh−2,500$85,300→ 26,667 totalExercise: $23.30Exp: 2033-01-03→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
- [F2]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001766433
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 6:15 PM ET
- Size
- 7.8 KB